• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌中生长抑素受体亚型表达与临床病理、Ki-67、Bcl-2及p53之间的关系

Relationship between somatostatin receptor subtype expression and clinicopathology, Ki-67, Bcl-2 and p53 in colorectal cancer.

作者信息

Qiu Cheng-Zhi, Wang Chuan, Huang Zhong-Xin, Zhu Shi-Ze, Wu You-Yi, Qiu Jian-Long

机构信息

Department of General Surgery, Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, Fujian Province, China.

出版信息

World J Gastroenterol. 2006 Apr 7;12(13):2011-5. doi: 10.3748/wjg.v12.i13.2011.

DOI:10.3748/wjg.v12.i13.2011
PMID:16610049
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4087677/
Abstract

AIM

To study the SSTR1, 2, 3, 4, 5 expression and their relationships with clinico-pathological factors, cell proliferation, Bcl-2 and p53 expression in colorectal cancer cells.

METHODS

Immunohistochemical staining of five SSTR subtypes, Ki-67, Bcl-2 and p53 was performed by the standard streptavidin-peroxidase (SP) technique for the paraffin sections of 127 colorectal cancers. and expression of five SSTR subtypes in 40 specimens of normal colorectal mucosae was detected with the same method.

RESULTS

Positive staining for five SSTR subtypes was observed in colorectal cancer cells and normal colorectal mucosae. SSTR1 was the most predominant subtype in both colorectal cancer and normal colorectal mucosa, and the second was SSTR5 or SSTR2. As compared with normal colorectal mucosa, SSTR4 was more frequently expressed in colorectal cancer cells (2.5% vs 18.9%, P<0.05); the expression of SSTR2, 4, 5 in moderately to well differentiated colorectal adenocarcinoma was significantly higher than that in poorly differentiated ones (P<0.05), the SSTR1 expression in colorectal cancer with positive lymph node metastasis was significantly higher than that with negative lymph node metastasis (72.2% and 54.5%,P<0.05). In addition, in the ulcerative type of colorectal cancer, SSTR2 expression was obviously decreased (P<0.05); the correlation did not reach a statistical significance between the five SSTR subtypes expression and Dukes'stages (P>0.05), but the frequency of SSTR1 expression increased with Dukes'stage, while SSTR3 and SSTR5 expression decreased with Dukes' stage. Moreover, there was no correlation between expression of the five SSTR subtypes and other clinicopathological factors such as age, sex, tumor site, tumor depth, distant metastasis. The proliferative indexes in colorectal cancer cells with negative expression of SSTR2 and SSTR3 were significantly higher than that with positive expression (P<0.05). The Bcl-2 expression in colorectal cancer cells with positive expression of SSTR1, 2, 3, 5 was significantly lower than that with negative expression (P<0.05). There was no correlation between five SSTR subtypes and p53 expression.

CONCLUSION

The most predominant SSTR subtype is SSTR1, and the second is SSTR2 or SSTR5. Five SSTR subtypes play different roles in the development of colorectal cancer. SSTR2 and SSTR3 can inhibit the proliferation and promote apoptosis of tumor cells.

摘要

目的

研究SSTR1、2、3、4、5在大肠癌细胞中的表达及其与临床病理因素、细胞增殖、Bcl-2和p53表达的关系。

方法

采用标准链霉亲和素-过氧化物酶(SP)技术对127例大肠癌石蜡切片进行5种SSTR亚型、Ki-67、Bcl-2和p53的免疫组化染色。用同样方法检测40例正常大肠黏膜中5种SSTR亚型的表达。

结果

在大肠癌细胞和正常大肠黏膜中均观察到5种SSTR亚型的阳性染色。SSTR1是大肠癌和正常大肠黏膜中最主要的亚型,其次是SSTR5或SSTR2。与正常大肠黏膜相比,SSTR4在大肠癌细胞中的表达更频繁(2.5%对18.9%,P<0.05);SSTR2、4、5在中高分化大肠腺癌中的表达明显高于低分化腺癌(P<0.05),有阳性淋巴结转移的大肠癌中SSTR1的表达明显高于无淋巴结转移者(72.2%和54.5%,P<0.05)。此外,在溃疡性大肠癌中,SSTR2的表达明显降低(P<0.05);5种SSTR亚型表达与Dukes分期之间的相关性未达到统计学意义(P>0.05),但SSTR1的表达频率随Dukes分期增加,而SSTR3和SSTR5的表达随Dukes分期降低。而且,5种SSTR亚型的表达与年龄、性别、肿瘤部位、肿瘤深度、远处转移等其他临床病理因素之间无相关性。SSTR2和SSTR3阴性表达的大肠癌细胞增殖指数明显高于阳性表达者(P<0.05)。SSTR1、2、3、5阳性表达的大肠癌细胞中Bcl-2的表达明显低于阴性表达者(P<0.05)。5种SSTR亚型与p53表达之间无相关性。

结论

最主要的SSTR亚型是SSTR1,其次是SSTR2或SSTR5。5种SSTR亚型在大肠癌的发生发展中发挥不同作用。SSTR2和SSTR3可抑制肿瘤细胞增殖并促进其凋亡。

相似文献

1
Relationship between somatostatin receptor subtype expression and clinicopathology, Ki-67, Bcl-2 and p53 in colorectal cancer.结直肠癌中生长抑素受体亚型表达与临床病理、Ki-67、Bcl-2及p53之间的关系
World J Gastroenterol. 2006 Apr 7;12(13):2011-5. doi: 10.3748/wjg.v12.i13.2011.
2
Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis.人胰岛细胞中五种生长抑素受体(hSSTR1 - 5)的亚型选择性表达:定量双标记免疫组织化学分析
Diabetes. 1999 Jan;48(1):77-85. doi: 10.2337/diabetes.48.1.77.
3
Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity.生长抑素受体mRNA在人脑膜瘤中的表达及其在体外抗增殖活性中的意义。
J Neurooncol. 2004 Jan;66(1-2):155-66. doi: 10.1023/b:neon.0000013498.19981.55.
4
Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology.原发性人类乳腺癌中的生长抑素受体:1 - 5型亚型mRNA的定量分析及其与受体蛋白表达和肿瘤病理学的相关性
Breast Cancer Res Treat. 2005 Jul;92(2):175-86. doi: 10.1007/s10549-005-2414-0.
5
Immunohistochemical expression and localization of somatostatin receptor subtypes in prostate cancer with neuroendocrine differentiation.免疫组织化学表达和定位在前列腺癌神经内分泌分化中的生长抑素受体亚型。
Int J Immunopathol Pharmacol. 2010 Apr-Jun;23(2):511-22. doi: 10.1177/039463201002300213.
6
Profiling of somatostatin receptor subtype expression by quantitative PCR and correlation with clinicopathological features in pancreatic endocrine tumors.采用定量 PCR 技术对生长抑素受体亚型表达谱进行分析,并与胰腺内分泌肿瘤的临床病理特征相关性研究。
Pancreas. 2010 Nov;39(8):1147-54. doi: 10.1097/MPA.0b013e3181e78120.
7
Somatostatin receptors and disease: role of receptor subtypes.生长抑素受体与疾病:受体亚型的作用
Baillieres Clin Endocrinol Metab. 1996 Jan;10(1):163-76. doi: 10.1016/s0950-351x(96)80362-4.
8
Ki-67, p53 and bcl-2 analysis in colonic versus rectal adenocarcinoma.结肠腺癌与直肠腺癌中Ki-67、p53和bcl-2的分析
Rom J Morphol Embryol. 2008;49(2):163-71.
9
Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.生长抑素受体亚型的鉴定及其对生长抑素类似物SMS 201-995治疗人类内分泌肿瘤疗效的影响。
J Clin Invest. 1994 Mar;93(3):1321-5. doi: 10.1172/JCI117090.
10
Somatostatin receptor subtype gene expression in pituitary adenomas.垂体腺瘤中生长抑素受体亚型基因表达
J Clin Endocrinol Metab. 1995 Apr;80(4):1386-92. doi: 10.1210/jcem.80.4.7714115.

引用本文的文献

1
Differences in the expression of CMTM3 and SSTR2 genes in right and left colon tumors: A molecular insight into colorectal cancer.CMTM3和SSTR2基因在左右结肠癌肿瘤中的表达差异:对结直肠癌的分子洞察
Med Oncol. 2025 Jul 28;42(9):382. doi: 10.1007/s12032-025-02961-5.
2
Differentially Expressed Somatostatin (SST) and Its Receptors (SST1-5) in Sporadic Colorectal Cancer and Normal Colorectal Mucosa.散发性结直肠癌和正常结直肠黏膜中差异表达的生长抑素(SST)及其受体(SST1 - 5)
Cancers (Basel). 2024 Oct 24;16(21):3584. doi: 10.3390/cancers16213584.
3
Thrombospondin 2, matrix Gla protein and digital analysis identified distinct fibroblast populations in fibrostenosing Crohn's disease.血小板反应蛋白 2、基质 Gla 蛋白和数字分析鉴定出纤维性狭窄性克罗恩病中不同的成纤维细胞群体。
Sci Rep. 2024 Jun 14;14(1):13810. doi: 10.1038/s41598-024-64672-7.
4
Somatostatin and Somatostatin Receptors in Tumour Biology.生长抑素及其受体在肿瘤生物学中的作用。
Int J Mol Sci. 2023 Dec 28;25(1):436. doi: 10.3390/ijms25010436.
5
CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.CX3CR1 在结直肠癌肿瘤微环境中作为一种保护性生物标志物。
Front Immunol. 2022 Jan 24;12:758040. doi: 10.3389/fimmu.2021.758040. eCollection 2021.
6
Somatostatin and Its Receptor System in Colorectal Cancer.结直肠癌中的生长抑素及其受体系统
Biomedicines. 2021 Nov 22;9(11):1743. doi: 10.3390/biomedicines9111743.
7
Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer.神经内分泌肿瘤和其他类型癌症中生长抑素和生长抑素受体的表观遗传调控。
Rev Endocr Metab Disord. 2021 Sep;22(3):495-510. doi: 10.1007/s11154-020-09607-z. Epub 2020 Oct 21.
8
Cetuximab Conjugated with Octreotide and Entrapped Calcium Alginate-beads for Targeting Somatostatin Receptors.西妥昔单抗与奥曲肽偶联并包埋于海藻酸钠珠用于靶向生长抑素受体。
Sci Rep. 2020 Mar 13;10(1):4736. doi: 10.1038/s41598-020-61605-y.
9
International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.国际基础和临床药理学联合会。生长抑素受体:结构、功能、配体和新命名。
Pharmacol Rev. 2018 Oct;70(4):763-835. doi: 10.1124/pr.117.015388.
10
Somatostatin receptor 2 signaling promotes growth and tumor survival in small-cell lung cancer.生长抑素受体 2 信号促进小细胞肺癌的生长和肿瘤存活。
Int J Cancer. 2019 Mar 1;144(5):1104-1114. doi: 10.1002/ijc.31771. Epub 2018 Oct 9.

本文引用的文献

1
Gene transfer of somatostatin receptor type 2 by intratumoral injection inhibits established pancreatic carcinoma xenografts.通过瘤内注射进行生长抑素2型受体的基因转移可抑制已形成的胰腺癌异种移植瘤。
World J Gastroenterol. 2005 Jan 28;11(4):516-20. doi: 10.3748/wjg.v11.i4.516.
2
Molecular signaling of somatostatin receptors.生长抑素受体的分子信号传导
Ann N Y Acad Sci. 2004 Apr;1014:121-31. doi: 10.1196/annals.1294.012.
3
sst2 Somatostatin receptor inhibits cell proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 activation.生长抑素受体2通过Ras、Rap1和B-Raf依赖的细胞外信号调节激酶2激活来抑制细胞增殖。
J Biol Chem. 2003 Oct 10;278(41):39356-71. doi: 10.1074/jbc.M304524200. Epub 2003 Jul 22.
4
Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis.生长抑素受体亚型2使人类胰腺癌细胞对死亡配体诱导的凋亡敏感。
Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):155-60. doi: 10.1073/pnas.0136771100. Epub 2002 Dec 18.
5
Antitumor effect of in vivo somatostatin receptor subtype 2 gene transfer in primary and metastatic pancreatic cancer models.体内生长抑素受体2型基因转移在原发性和转移性胰腺癌模型中的抗肿瘤作用
Cancer Res. 2002 Nov 1;62(21):6124-31.
6
The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing?生长抑素类似物作为抗肿瘤药物的临床作用:小题大做?
Ann Oncol. 2002 May;13(5):653-68. doi: 10.1093/annonc/mdf142.
7
Quantitative evaluation of somatostatin receptor subtype 2 expression in sporadic colorectal tumor and in the corresponding normal mucosa.散发性结直肠肿瘤及相应正常黏膜中生长抑素受体2型表达的定量评估
Clin Cancer Res. 2002 Feb;8(2):419-27.
8
Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands.使用亚型选择性配体的受体放射自显影技术检测生长抑素受体sst1 - sst5在正常和肿瘤性人体组织中的表达
Eur J Nucl Med. 2001 Jul;28(7):836-46. doi: 10.1007/s002590100541.
9
The antitumor somatostatin analogue TT-232 induces cell cycle arrest through PKCdelta and c-Src.抗肿瘤生长抑素类似物TT-232通过蛋白激酶Cδ(PKCδ)和原癌基因酪氨酸蛋白激酶c-Src诱导细胞周期停滞。
Biochem Biophys Res Commun. 2001 Jul 13;285(2):483-8. doi: 10.1006/bbrc.2001.5199.
10
Modulation of potassium current and calcium influx by somatostatin in rod bipolar cells isolated from the rabbit retina via sst2 receptors.
Naunyn Schmiedebergs Arch Pharmacol. 2001 Jun;363(6):680-94. doi: 10.1007/s002100100422.